Siemens Healthineers AG said Monday that profit and revenue rose in the second quarter on the back of strong demand, and raised its outlook for the full year.
The German medical-equipment maker said quarterly net profit came in at 447 million euros ($537.3 million) from EUR414 million a year earlier.
Revenue was EUR3.97 billion in the period, up from EUR3.69 billion during the same period the year prior, a 12.9% increase on a comparable basis. The result was supported by continued demand for rapid Covid-19 antigen tests boosting the Diagnostic segment.
"As a result of the very strong revenue development in the second quarter, ongoing pandemic-related demand, higher confidence in the normalization of the business development as well as the closing of the Varian acquisition, we again raise our outlook for fiscal year 2021," Siemens Healthineers said.
The company now targets comparable revenue growth of between 14% and 17% compared with a previous target of 8% to 12%. Adjusted basic earnings per share are seen at between EUR1.90 and EUR2.05, up from EUR1.63 and EUR1.82 previously.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.